Diet and gut microbiome in fatty liver and its associated liver cancer

被引:24
|
作者
Pan, Yasi
Zhang, Xiang
机构
[1] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, CUHK Shenzhen Res Inst, State Key Lab Digest Dis,Inst Digest Dis,Shatin, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, CUHK Shenzhen Res Inst, Dept Med & Therapeut,Shatin, Hong Kong, Peoples R China
基金
中国国家自然科学基金;
关键词
diet; gut microbiome; HCC; NASH; NONALCOHOLIC STEATOHEPATITIS; INTESTINAL MICROBIOTA; FRUCTOSE CONSUMPTION; INSULIN-RESISTANCE; ADVANCED FIBROSIS; SATURATED FAT; HONG-KONG; DISEASE; OBESITY; ACIDS;
D O I
10.1111/jgh.15713
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Non-alcoholic fatty liver disease (NAFLD) is the major cause of chronic liver disease worldwide as a consequence of a sedentary lifestyle and overnutrition. NAFLD could progress to non-alcoholic steatohepatitis (NASH), which may further develop to cirrhosis and hepatocellular carcinoma (HCC). The gut microbiome is one of the central regulators in host metabolism. Diet could change human gut microbiome rapidly and reproducibly and modulate several metabolic pathways. Both diet and gut microbiome dysbiosis are associated with NAFLD and its related HCC (NAFLD-HCC). Dietary cholesterol, fiber, fat, or carbohydrate could change the microbiome composition to contribute to the development of NASH and NAFLD-HCC. Hence, identification of elements of the gut-liver axis that are primarily damaged in NASH and NAFLD-HCC offers new possibility for therapeutic intervention. In this review, the roles of gut microbiome and microbial metabolites in the development and progression of NAFLD and NAFLD-HCC are first discussed. The impacts of different diet compositions including cholesterol, fiber, fat, and sugar on the gut microbiome that leads to predisposition to NASH and NAFLD-HCC are also explored. We summarized the article by discussing potential therapeutic implication of diet and microbiome modulation in fatty liver and liver cancer.
引用
收藏
页码:7 / 14
页数:8
相关论文
共 50 条
  • [1] Nonalcoholic Fatty Liver Disease, the Gut Microbiome, and Diet
    Mokhtari, Zeinab
    Gibson, Deanna L.
    Hekmatdoost, Azita
    ADVANCES IN NUTRITION, 2017, 8 (02) : 240 - 252
  • [2] GUT MICROBIOME MODULATES HOST TRANSCRIPTION IN DIETARY CHOLESTEROL-INDUCED FATTY LIVER-ASSOCIATED LIVER CANCER
    Zhang, Xiang
    Zeng, Tao
    Lau, Harry C.
    Coker, Olabisi O.
    Chu, Eagle S.
    Yu, Jun
    GASTROENTEROLOGY, 2022, 162 (07) : S1243 - S1243
  • [3] Nonalcoholic fatty liver disease and the gut microbiome: Are bacteria responsible for fatty liver?
    Dong, Tien S.
    Jacobs, Jonathan P.
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2019, 244 (06) : 408 - 418
  • [4] Nonalcoholic Fatty Liver Disease and the Gut Microbiome
    Boursier, Jerome
    Diehl, Anna Mae
    CLINICS IN LIVER DISEASE, 2016, 20 (02) : 263 - +
  • [5] Gut microbiome and nonalcoholic fatty liver diseases
    Lixin Zhu
    Robert D. Baker
    Susan S. Baker
    Pediatric Research, 2015, 77 : 245 - 251
  • [6] Gut microbiome and nonalcoholic fatty liver diseases
    Zhu, Lixin
    Baker, Robert D.
    Baker, Susan S.
    PEDIATRIC RESEARCH, 2015, 77 (01) : 245 - 251
  • [7] Gut microbiome and nonalcoholic fatty liver disease
    Meng-Yuan Wu
    Jian-Gao Fan
    Hepatobiliary & Pancreatic Diseases International, 2023, 22 (05) : 444 - 451
  • [8] Gut microbiome and nonalcoholic fatty liver disease
    Wu, Meng -Yuan
    Fan, Jian-Gao
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2023, 22 (05) : 444 - 451
  • [9] Gut microbiome profiles associated with steatosis severity in metabolic associated fatty liver disease
    Dong, Tien S.
    Luu, Kayti
    Lagishetty, Venu
    Sedighian, Farzaneh
    Woo, Shih-Lung
    Dreskin, Benjamin W.
    Katzka, William
    Chang, Candace
    Zhou, Yi
    Arias-Jayo, Nerea
    Yang, Julianne
    Ahdoot, Aaron I.
    Ye, Jason
    Li, Zhaoping
    Pisegna, Joseph R.
    Jacobs, Jonathan P.
    HEPATOMA RESEARCH, 2021, 7
  • [10] The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease
    Jennison, Erica
    Byrne, Christopher D.
    CLINICAL AND MOLECULAR HEPATOLOGY, 2021, 27 (01) : 22 - 43